SANTA CLARA - Agilent Technologies Inc. today announced the launch of the Agilent SureSelect Cancer CGP Assay designed for somatic variant profiling for a broad range of solid tumor types.
The. | April 14, 2023
Agilent Technologies Inc has unveiled the Agilent SureSelect Cancer CGP Assay, a next-generation sequencing (NGS) panel designed for somatic variant profiling in a wide range of solid tumour types. Click to read more.
Collaboration provides a solution for a more in-depth analysis of cancer biomarkers SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and the leader in data-driven